Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age

Carlos E. Vigil, Wei Tan, George Deeb, Sheila N. Sait, Annemarie W. Block, Petr Starostik, Elizabeth A. Griffiths, James E. Thompson, Jessica D. Greene, Laurie A. Ford, Eunice S. Wang, Meir Wetzler^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review